Applying our synthetic lethality expertise for better cancer therapies
Our vision is to discover and develop new cancer therapies that dramatically extend and improve patients’ lives.
Anticancer Bioscience is an exciting international precision oncology company, applying synthetic lethal approaches to develop targeted cancer therapies. We have been formed to commercialize the discoveries emerging from China’s prestigious J. Michael Bishop Institute of Cancer Research.
We are applying our innovative chemical and natural product libraries and discovery platforms in cancer biology, to identify novel mechanisms to induce cancer cell death, without harming healthy cells. This will enable us to develop breakthrough precision cancer therapies that are safer and more effective.
Our ambitious research and development teams are pioneers in cancer research, innovating genetic tools such as synthetic lethality and the design of novel high-throughput screening approaches. We operate globally from headquarters in Chengdu, China, as well as in India, Australia, the United Kingdom, and the United States.
“Our mission is to apply our innovative libraries and platforms in cancer biology, to discover novel mechanisms to induce cancer cell death, without harming healthy cells. This will enable us to develop breakthrough precision cancer therapies that are safer and more effective..”
President & CEO at Anticancer Bioscience